Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa A Jackson

Showing results (141-150 of 246) with videos related to

Pageof 25
Sort By:
American Journal of Epidemiology|January 8, 2013
Adapting group sequential methods to observational postlicensure vaccine safety surveillance: results of a pentavalent combination DTaP-IPV-Hib vaccine safety studyJennifer C Nelson, Onchee Yu, Clara P Dominguez-Islas, et al.
International Journal of Medical Informatics|May 27, 2019
The use of natural language processing to identify Tdap-related local reactions at five health care systems in the Vaccine Safety DatalinkChengyi Zheng, Wei Yu, Fagen Xie, et al.
Vaccine|November 15, 2022
Burden of medically attended influenza infection and cases averted by vaccination - United States, 2016/17 through 2018/19 influenza seasonsMichael L Jackson, C Hallie Phillips, Stacie Wellwood, et al.
NPJ Vaccines|November 24, 2025
Safety and immunogenicity of the Sm-p80 GLA-SE schistosomiasis vaccineLisa A Jackson, Rhea N Coler, Gregory A Deye, et al.
Vaccine|May 17, 2021
Sample size considerations for mid-season estimates from a large influenza vaccine effectiveness network in the United StatesJessie R Chung, Brendan Flannery, Sara S Kim, et al.
Human Vaccines & Immunotherapeutics|June 8, 2026
Retrospective cohort study of mRNA COVID-19 vaccine-associated enhanced disease in the Vaccine Safety Datalink, 2021-23Edward A Belongia, Burney A Kieke, Kayla E Hanson, et al.
Open Forum Infectious Diseases|July 17, 2015
Hemagglutination Inhibition Antibody Titers as a Correlate of Protection Against Seasonal A/H3N2 Influenza DiseaseAnne Benoit, Jiri Beran, Jeanne-Marie Devaster, et al.
Plos Pathogens|May 28, 2021
PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: A randomized, placebo-controlled trial with controlled human malaria infectionSean C Murphy, Gregory A Deye, B Kim Lee Sim, et al.
Open Forum Infectious Diseases|February 4, 2021
Clinical Symptoms Among Ambulatory Patients Tested for SARS-CoV-2Jessie R Chung, Sara S Kim, Michael L Jackson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 7, 2020
Effects of Prior Season Vaccination on Current Season Vaccine Effectiveness in the United States Flu Vaccine Effectiveness Network, 2012-2013 Through 2017-2018Sara S Kim, Brendan Flannery, Ivo M Foppa, et al.
Pageof 25

Showing results (141-150 of 246) with videos related to

Sort By:
Pageof 25
American Journal of Epidemiology|January 8, 2013
Adapting group sequential methods to observational postlicensure vaccine safety surveillance: results of a pentavalent combination DTaP-IPV-Hib vaccine safety studyJennifer C Nelson, Onchee Yu, Clara P Dominguez-Islas, et al.
International Journal of Medical Informatics|May 27, 2019
The use of natural language processing to identify Tdap-related local reactions at five health care systems in the Vaccine Safety DatalinkChengyi Zheng, Wei Yu, Fagen Xie, et al.
Vaccine|November 15, 2022
Burden of medically attended influenza infection and cases averted by vaccination - United States, 2016/17 through 2018/19 influenza seasonsMichael L Jackson, C Hallie Phillips, Stacie Wellwood, et al.
NPJ Vaccines|November 24, 2025
Safety and immunogenicity of the Sm-p80 GLA-SE schistosomiasis vaccineLisa A Jackson, Rhea N Coler, Gregory A Deye, et al.
Vaccine|May 17, 2021
Sample size considerations for mid-season estimates from a large influenza vaccine effectiveness network in the United StatesJessie R Chung, Brendan Flannery, Sara S Kim, et al.
Human Vaccines & Immunotherapeutics|June 8, 2026
Retrospective cohort study of mRNA COVID-19 vaccine-associated enhanced disease in the Vaccine Safety Datalink, 2021-23Edward A Belongia, Burney A Kieke, Kayla E Hanson, et al.
Open Forum Infectious Diseases|July 17, 2015
Hemagglutination Inhibition Antibody Titers as a Correlate of Protection Against Seasonal A/H3N2 Influenza DiseaseAnne Benoit, Jiri Beran, Jeanne-Marie Devaster, et al.
Plos Pathogens|May 28, 2021
PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: A randomized, placebo-controlled trial with controlled human malaria infectionSean C Murphy, Gregory A Deye, B Kim Lee Sim, et al.
Open Forum Infectious Diseases|February 4, 2021
Clinical Symptoms Among Ambulatory Patients Tested for SARS-CoV-2Jessie R Chung, Sara S Kim, Michael L Jackson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 7, 2020
Effects of Prior Season Vaccination on Current Season Vaccine Effectiveness in the United States Flu Vaccine Effectiveness Network, 2012-2013 Through 2017-2018Sara S Kim, Brendan Flannery, Ivo M Foppa, et al.
Pageof 25